Protagonist Therapeutics Stock Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 8.35%

The Protagonist Therapeutics Inc stock price gained 3.42% on the last trading day (Tuesday, 23rd Jun 2026), rising from $115.03 to $118.96. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.67% from a day low at $114.50 to a day high of $119.85. The price has risen in 7 of the last 10 days and is up by 21.35% over the past 2 weeks. Volume fell on the last day by -558 thousand shares and in total, 635 thousand shares were bought and sold for approximately $75.58 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to rise 4.31% during the next 3 months and, with a 90% probability hold a price between $98.40 and $124.08 at the end of this 3-month period.

PTGX Signals & Forecast

Mostly positive signals in the chart today. The Protagonist Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $113.02 and $103.25. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 27.60%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Protagonist Therapeutics Inc stock

Protagonist Therapeutics Inc finds support from accumulated volume at $115.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $5.35 between high and low, or 4.67%. For the last week, the stock has had daily average volatility of 3.59%.

The Protagonist Therapeutics Inc stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $115.56 (-2.86%) (This stock has high daily movements and this gives high risk. The RSI14 is 82 and this increases the risk substantially. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (PTGX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Protagonist Therapeutics Inc to open at $117.77, and during the day (based on 14 day Average True Range), to move between $116.72 and $121.20, which gives a possible trading interval of +/-$4.47 (+/-3.83%) up or down from last closing price. If Protagonist Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 3.83% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $115.03, some $3.93 (3.30%) from the current price of $118.96, our system finds the risk reward attractive.

Is Protagonist Therapeutics Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Protagonist Therapeutics Inc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 4.727 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $117.77 ( 1.00%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk